Loading...
TGAT
SIBM
Market cap16mUSD
, Last price  
EUR
Name

Sirona Biochem Corp

Chart & performance

D1W1MN
TGAT:SIBM chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
7.98%
Rev. 5Y
-51.37%
Div Yld LY
—
Div Yld TTM
—
Revenues
35k
-94.82%
00000000207,7377,995360,5005,4681,278,695135,743105,711268,022671,92334,779
Net income
-3m
L-28.52%
-6-218,125-97,082-1,215,771-1,069,650-2,505,659-2,983,286-2,784,595-3,525,675-3,546,142-2,974,767-4,460,394-1,273,246-4,549,575-4,133,724-2,306,335-3,557,804-2,543,190
CFO
-2m
L-19.29%
-6-84,776-115,397-1,151,203-842,703-2,522,626-2,144,535-2,607,206-1,859,780-2,584,021-2,103,256-2,498,852-653,801-3,559,490-2,112,104-2,158,227-2,177,512-1,757,512

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sirona Biochem Corp. operates as a biotechnology company dedicated to uncovering and commercializing active ingredients for both cosmetic and pharmaceutical uses, with a commercial presence in Canada and France. Key initiatives include the development of a cosmetic skin brightener and a pharmaceutical solution for diabetes. Beyond these, the company is engaged in several other projects, such as building a library of anti-aging and cell-protective compounds, creating a novel anti-wrinkle agent, and pursuing an antiviral research program. A notable collaboration exists with the International Centre for Genetic Engineering and Biotechnology (ICGEB) for the joint development of an antiviral compound library. Established in 2006, the business, originally named High Rider Capital Inc., rebranded as Sirona Biochem Corp. in May 2009 and maintains its headquarters in Vancouver, Canada.

Key people

Howard Verrico
Chairman of the Board, Interim Chief Executive Officer, Founder, Secretary · since 2014
Geraldine Deliencourt-Godefroy
Chief Scientific Officer, Director · since 2012
Attila Hajdu
Chief Business Development Officer · since 2014
Christopher D. Hopton
Chief Financial Officer, Director · since 2011
Alex Marazzi
Independent Director · since 2006
IPO date
Jul 10, 2007
Employees
Domiciled in
CA
Incorporated in
CA
Headquarters & legal address
889 West Pender Street
Suite 605
Vancouver, BC V6C 3B2
CA
Previous name
High Rider Capital Inc.

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑102022‑102021‑102020‑102019‑102018‑102017‑102016‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT